About The Mark Foundation for Cancer Research
The Mark Foundation for Cancer Research is a Healthcare company based in New York (United States). Funding is provided for innovative cancer research initiatives. It operates on a Donation / Grant-Based model. The Mark Foundation for Cancer Research offers products and services including Cancer Research Grants and Fellowships. Its focus areas include Biotechnology and Cancer Research.
Company details
The Mark Foundation for Cancer Research is dedicated to accelerating groundbreaking cancer research through substantial funding and grants. Over 300 grants totaling more than 275 million have been awarded to investigators at over 110 institutions across 18 countries. Various programs such as ASPIRE, Emerging Leader, and Endeavor Awards are supported to foster proof-of-concept projects, early career researchers, and large-scale collaborative efforts. Partnerships and investments are also facilitated to drive advancements in drug discovery, early detection, and innovative cancer therapies within the healthcare and biotechnology sectors.
- Headquarters New York, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website themarkfoundation.org
- Social LinkedIn X Facebook Instagram
Products & Services of The Mark Foundation for Cancer Research
The Mark Foundation for Cancer Research offers a comprehensive portfolio of products and services, including Cancer Research Grants and Fellowships.
Grants are provided to support innovative cancer research.
Fellowships are offered to early career cancer researchers.
Top companies in Immunology & Cancer Therapeutics
3 companies that operate in the same segment as The Mark Foundation for Cancer Research (Immunology & Cancer Therapeutics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | |||
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about The Mark Foundation for Cancer Research
The Mark Foundation for Cancer Research is headquartered in New York, United States. It is registered at New York, New York, United States.
The Mark Foundation for Cancer Research is dedicated to accelerating groundbreaking cancer research through substantial funding and grants. Over 300 grants totaling more than 275 million have been awarded to investigators at over 110 institutions across 18 countries. Various programs such as ASPIRE, Emerging Leader, and Endeavor Awards are supported to foster proof-of-concept projects, early career researchers, and large-scale collaborative efforts. Partnerships and investments are also facilitated to drive advancements in drug discovery, early detection, and innovative cancer therapies within the healthcare and biotechnology sectors.
The Mark Foundation for Cancer Research offers Cancer Research Grants and Fellowships.